This study compared potentially inappropriate medications (PIMs) using three criteria (BEERS 2019, STOPP v2, and FORTA 2021) in hospitalized older adults in Southern India. In this cross-sectional study of 597 patients (mean age: 72.80 ± 7.41 years), PIM prevalence was remarkably high across all criteria: BEERS (99.33%), STOPP (99.16%), and FORTA (99.83%). The mean PIMs per patient were: BEERS (3.89 ± 1.84), STOPP (3.77 ± 1.92), and FORTA (7.94 ± 3.22). Cohen’s kappa showed fair agreement between BEERS and STOPP criteria (κ = 0.252, p < .001), but poor agreement with FORTA. Bland–Altman analysis indicated acceptable agreement between each tool and mean standardized PIM value. The number of medications during hospitalization was the only significant predictor of PIM use in both BEERS (OR = 2.504, p = .008) and STOPP criteria (OR = 1.685, p = .008). Results highlight the need for systematic medication review.
AkazawaM.ImaiH.IgarashiA.TsutaniK. (2010). Potentially inappropriate medication use in elderly Japanese patients. The American Journal of Geriatric Pharmacotherapy, 8(2), 146–160. https://doi.org/10.1016/j.amjopharm.2010.03.005
2.
American Geriatrics Society 2019. (2019). Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
3.
AnandP.KatyalJ.DeyA. B.GuptaY. K. (2022). Characterization of potentially inappropriate medications use in Indian elderly population and their impact on quality of life using Beers criteria. Aging medicine (Milton (N.S.W)), 5(1), 45–52. https://doi.org/10.1002/agm2.12194
4.
AwadA.HannaO. (2019). Potentially inappropriate medication use among geriatric patients in primary care setting: A cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS One, 14(6), Article e0218174. https://doi.org/10.1371/journal.pone.0218174
BonyH.LloydR. A.HothamE. D.CorreL. J.CorlisM. E.LofflerH. A.ScarlettG. K.TsimbinosJ. M.ToddI. P.SuppiahV. (2020). Differences in the prescribing of potentially inappropriate medicines in older Australians: Comparison of community dwelling and residential aged care residents. Scientific Reports, 10(1), Article 10170. https://doi.org/10.1038/s41598-020-66991-x
7.
ChaudhuriA. (2012). Socio-economic inequity in health care utilization & expenditures in richer states in India. Indian Journal of Medical Research, 136(3), 368–369.
8.
ClarkC. M.ShaverA. L.AurelioL. A.FeuersteinS.WahlerR. G.DalyC. J.JacobsD. M. (2020). Potentially inappropriate medications are associated with increased healthcare utilization and costs. Journal of the American Geriatrics Society, 68(11), 2542–2550. https://doi.org/10.1111/jgs.16743
9.
EarlT. R.KatapodisN. D.SchneidermanS. R. (2020). Making healthcare safer III: A critical analysis of existing and emerging patient safety practices. Agency for Healthcare Research and Quality (US). https://www.ncbi.nlm.nih.gov/books/NBK555524/
10.
EndresH. G.Kaufmann-KolleP.SteebV.BauerE.BöttnerC.ThürmannP. (2016). Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: An observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS One, 11(2), Article e0146811. https://doi.org/10.1371/journal.pone.0146811
11.
GallagherP.LangP. O.CherubiniA.TopinkováE.Cruz-JentoftA.Montero ErrasquínB.MádlováP.GasperiniB.BaeyensH.BaeyensJ. P.MichelJ. P.O’MahonyD. (2011). Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. European Journal of Clinical Pharmacology, 67(11), 1175–1188. https://doi.org/10.1007/s00228-011-1061-0
12.
GodmanB.McCabeH.D LeongT.MuellerD.MartinA. P.HoxhaI.MwitaJ. C.RwegereraG. M.MasseleA.CostaJ. d. O.do NascimentoR. C. R. M.LemosL. L. P. D.TachkovK.MilushewaP.PatrickO.NibaL. L.LaiusO.SefahI.AbdulsalimS.…MeyerJ. C. (2020). Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics & Outcomes Research, 20(1), 1–26. https://doi.org/10.1080/14737167.2020.1734456
13.
HeiderD.MatschingerH.MeidA. D.QuinzlerR.AdlerJ.-B.GünsterC.HaefeliW. E.KönigH.-H. (2017). Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: Retrospective matched cohort study. Drugs & Aging, 34(4), 289–301. https://doi.org/10.1007/s40266-017-0441-2
14.
HoltS.SchmiedlS.ThürmannP. A. (2010). Potentially inappropriate medications in the elderly. Deutsches Arzteblatt International, 107(31–32), 543–551. https://doi.org/10.3238/arztebl.2010.0543
15.
HyttinenV.TaipaleH.TolppanenA.-M.TanskanenA.TiihonenJ.HartikainenS.ValtonenH. (2017). Incident use of a potentially inappropriate medication and hip fracture in community-dwelling older Persons with alzheimer’s disease. The Annals of Pharmacotherapy, 51(9), 725–734. https://doi.org/10.1177/1060028017708394
16.
JeonH.-L.ParkJ.HanE.KimD.-S. (2018). Potentially inappropriate medication and hospitalization/emergency department visits among the elderly in Korea. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care, 30(1), 50–56. https://doi.org/10.1093/intqhc/mzx171
17.
KumarS.CastelinoR.RaoA.GattaniS.KumarA.PillaiA.SehgalA.RaneP.RamaswamyA.DhekaleR.KrishnamurthyJ.BanavaliS.BadweR.PrabhashK.NoronhaV.GotaV. (2024). Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine, 13(1), Article e6797. https://doi.org/10.1002/cam4.6797
18.
LandisJ. R.KochG. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.
19.
MaZ.ZhangC.CuiX.LiuL. (2018). Comparison of three criteria for potentially inappropriate medications in Chinese older adults. Clinical Interventions in Aging, 14, 65–72. https://doi.org/10.2147/CIA.S190983
20.
MalakoutiS. K.Javan-NoughabiJ.YousefzadehN.RezapourA.MortazaviS. S.JahangiriR.MoghriJ. (2021). A systematic review of potentially inappropriate medications use and related costs among the elderly. Value in Health Regional Issues, 25, 172–179. https://doi.org/10.1016/j.vhri.2021.05.003
21.
McHughM. L. (2012). Interrater reliability: The kappa statistic. Biochemia Medica, 22(3), 276–282.
22.
McMaughanD. J.OloruntobaO.SmithM. L. (2020). Socioeconomic status and access to healthcare: Interrelated drivers for healthy aging. Frontiers in Public Health, 8, 231. https://doi.org/10.3389/fpubh.2020.00231
23.
MillarA.HughesC.RyanC. (2017). Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: A cross-sectional observational study. International Journal of Clinical Pharmacy, 39(3), 527–535. https://doi.org/10.1007/s11096-017-0452-4
24.
MorinL.LarocheM.-L.TexierG.JohnellK. (2016). Prevalence of potentially inappropriate medication use in older adults living in nursing homes: A systematic review. Journal of the American Medical Directors Association, 17(9), 862.e1–862.e9. https://doi.org/10.1016/j.jamda.2016.06.011
25.
MuhlackD. C.HoppeL. K.WeberpalsJ.BrennerH.SchöttkerB. (2017). The association of potentially inappropriate medication at older age with cardiovascular events and Overall mortality: A systematic review and meta-analysis of cohort studies. Journal of the American Medical Directors Association, 18(3), 211–220. https://doi.org/10.1016/j.jamda.2016.11.025
O’MahonyD.O’SullivanD.ByrneS.O’ConnorM. N.RyanC.GallagherP. (2014). STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age and Ageing, 44(2), 213–218. https://doi.org/10.1093/ageing/afu145
28.
PandeyM. M.RastogiS.RawatA. K. S. (2013). Indian traditional ayurvedic system of medicine and nutritional supplementation. Evidence-based Complementary and Alternative Medicine: eCAM, 2013, 1–12. https://doi.org/10.1155/2013/376327
29.
PazanF.WeissC.WehlingM.BauerJ. M.BertholdH. K.DenkingerM.ArnimC. V.DovjakP.FrohnhofenH.GoschM.GutzmannH.Heuser-CollierI.HoneckerF.HüllM.IglsederB.JaehdeU.KressigR. W.KwetkatA.SchindlerC.…WeddingU. (2022). The FORTA (Fit fOR the aged) list 2021: Fourth version of a validated clinical aid for improved pharmacotherapy in older adults. Drugs & Aging, 39(3), 245–247. https://doi.org/10.1007/s40266-022-00922-5
30.
PerpétuoC.PlácidoA. I.RodriguesD.ApertaJ.Piñeiro-LamasM.FigueirasA.HerdeiroM. T.RoqueF. (2021). Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: Concordance and overlap among the EU(7)-PIM list and Beers and STOPP criteria. Frontiers in Pharmacology, 12, Article 676020. https://doi.org/10.3389/fphar.2021.676020
31.
RajanS. I.MishraU. S. (2011). The National Policy for Older Persons: Critical Issues in Implementation. BKPAI Working Paper No. 5, United Nations Population Fund (UNFPA), New Delhi.
32.
Renom-GuiterasA.MeyerG.ThürmannP. A. (2015). The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries. European Journal of Clinical Pharmacology, 71(7), 861–875. https://doi.org/10.1007/s00228-015-1860-9
33.
Renom-GuiterasA.ThürmannP. A.MirallesR.Klaaßen-MielkeR.ThiemU.StephanA.BleijlevensM. H. C.JolleyD.Leino-KilpiH.Rahm HallbergI.SaksK.Soto-MartinM.ZabaleguiA.MeyerG.RightTimePlaceCare Consortium. (2018). Potentially inappropriate medication among people with dementia in eight European countries. Age and Ageing, 47(1), 68–74. https://doi.org/10.1093/ageing/afx147
34.
SangeethaR.CharanK. S.SantanaB.KumariM.MuraliP.PriyaGh. (2022). Drugs banned in other countries, still prevailing in India, a vital matter of concern—a narrative review. Journal of Dr. NTR University of Health Sciences, 11(4), 259. https://doi.org/10.4103/jdrntruhs.jdrntruhs_134_22
35.
San-JoséA.AgustíA.VidalX.FormigaF.Gómez-HernándezM.GarcíaJ.López-SotoA.Ramírez-DuqueN.TorresO. H.BarbéJ.Potentially Inappropriate Prescription in Older Patients in Spain PIPOPS Investigators’ project. (2015). Inappropriate prescribing to the oldest old patients admitted to hospital: Prevalence, most frequently used medicines, and associated factors. BMC Geriatrics, 15(1), 42. https://doi.org/10.1186/s12877-015-0038-8
SinglaR.BindraJ.SinglaA.GuptaY.KalraS. (2019). Drug prescription patterns and cost analysis of diabetes therapy in India: Audit of an endocrine practice. Indian Journal of Endocrinology and Metabolism, 23(1), 40–45. https://doi.org/10.4103/ijem.IJEM_646_18
38.
SyedJ.ChalasaniS. H. (2024). The 2023 American geriatrics society updated Beers criteria ® application in low- and middle-income countries: A walk-through. The Senior Care Pharmacist, 39(8), 286–290. https://doi.org/10.4140/TCP.n.2024.286
39.
SyedJ.VermaA.ChopraV.KhemchandaniV.PereiraP.PatilV.RameshM.ChalasaniS. H. (2024). De-Med—a tool to identify and classify potentially inappropriate medication according to Beers criteria, STOPP, and FORTA: A cross-sectional study. Journal of Pharmaceutical Health Services Research, 15(4), rmae026. https://doi.org/10.1093/jphsr/rmae026
40.
TianF.ChenZ.ZengY.FengQ.ChenX. (2023). Prevalence of use of potentially inappropriate medications among older adults worldwide. JAMA Network Open, 6(8), Article e2326910. https://doi.org/10.1001/jamanetworkopen.2023.26910
41.
VargaS.AlcuskyM.KeithS. W.HegartyS. E.Del CanaleS.LombardiM.MaioV. (2017). Hospitalization rates during potentially inappropriate medication use in a large population‐based cohort of older adults. British Journal of Clinical Pharmacology, 83(11), 2572–2580. https://doi.org/10.1111/bcp.13365
42.
WickopB.HärterichS.SommerC.DaubmannA.BaehrM.LangebrakeC. (2016). Potentially inappropriate medication use in multimorbid elderly inpatients: Differences between the FORTA, PRISCUS and STOPP ratings. Drugs - Real World Outcomes, 3(3), 317–325. https://doi.org/10.1007/s40801-016-0085-2
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
